Cargando…
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis
AIM: To test the contribution of programmed cell death 4 (PDCD4) tumour suppressor gene in Barrett's carcinogenesis. METHODS: PDCD4 immunohistochemical expression was assessed in 88 biopsy samples obtained from histologically proven long-segment Barrett's mucosa (BM; 25 non-intestinal colu...
Autores principales: | Fassan, Matteo, Pizzi, Marco, Battaglia, Giorgio, Giacomelli, Luciano, Parente, Paola, Bocus, Paolo, Ancona, Ermanno, Rugge, Massimo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976066/ https://www.ncbi.nlm.nih.gov/pubmed/20702469 http://dx.doi.org/10.1136/jcp.2010.078253 |
Ejemplares similares
-
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma
por: Galuppini, Francesca, et al.
Publicado: (2019) -
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis
por: Fassan, Matteo, et al.
Publicado: (2014) -
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia
por: Fassan, Matteo, et al.
Publicado: (2013) -
Role of Confocal Laser Endomicroscopy in Detection of Residual Barrett's Esophagus after Radiofrequency Ablation
por: Diamantis, Giorgio, et al.
Publicado: (2011) -
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
por: Fassan, Matteo, et al.
Publicado: (2016)